These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 5576185)
21. [Hormonal treatment in women and thrombosis]. Kaaja R; Heikinheimo O; Rasi V Duodecim; 1999; 115(11):1235-43. PubMed ID: 11877844 [No Abstract] [Full Text] [Related]
22. [Oral contraceptives and thrombosis--a comment]. Astedt B Lakartidningen; 1995 Dec; 92(51-52):4872. PubMed ID: 8544505 [No Abstract] [Full Text] [Related]
23. [Are oral contraceptives responsible for thrombosis?]. Lechat P Cah Coll Med Hop Paris; 1967 May; 8(6):447-9. PubMed ID: 5609551 [No Abstract] [Full Text] [Related]
24. [Vascular thrombosis related to oral contraceptives and antiethinylestradiol antibodies--epidemiology and prevention (author's transl)]. Beaumont V; Beaumont JL Ther Umsch; 1982 Feb; 39(2):109-13. PubMed ID: 6461942 [TBL] [Abstract][Full Text] [Related]
25. [Oral contraceptives and the incidence of thrombosis]. Abrahamsen AF Tidsskr Nor Laegeforen; 1970 Feb; 90(4):403-8. PubMed ID: 5426472 [No Abstract] [Full Text] [Related]
26. [Oral contraceptives to women which run special risks]. Lidegaard Ø; Poulsen EF; Schiødt AV Ugeskr Laeger; 2001 Aug; 163(34):4546-8. PubMed ID: 11530556 [No Abstract] [Full Text] [Related]
30. [Oral contraceptives increase the chance of venous thrombosis in factor V Leiden mutation]. Huikeshoven FJ; Lotgering FK Ned Tijdschr Geneeskd; 1995 Jul; 139(30):1561-2. PubMed ID: 7675138 [No Abstract] [Full Text] [Related]
31. Thrombotic risk factors and oral contraception. Bokarewa MI; Falk G; Sten-Linder M; Egberg N; Blombäck M; Bremme K J Lab Clin Med; 1995 Sep; 126(3):294-8. PubMed ID: 7665978 [TBL] [Abstract][Full Text] [Related]
32. [Current aspects of thrombosis and oral contraceptives]. Astedt B Katilolehti; 1975 May; 80(5):216-20. PubMed ID: 1040042 [No Abstract] [Full Text] [Related]
33. Thrombosis--perspective on a major side effect of oral contraceptives. Carey HM Med J Aust; 1976 Dec 18-25; 2(25-26):962. PubMed ID: 1018683 [TBL] [Abstract][Full Text] [Related]
35. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives]. Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622 [TBL] [Abstract][Full Text] [Related]
36. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives. Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614 [TBL] [Abstract][Full Text] [Related]
37. [Thrombotic complications in a young woman during ovocyston therapy]. Babińska Z; Lachowski M Wiad Lek; 1970 Feb; 23(4):333-6. PubMed ID: 5439262 [No Abstract] [Full Text] [Related]
38. [Retinal arterial thrombosis and oral estroprogestatives]. Bardenat M; Amalric P; Delpech J Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(5):695-6. PubMed ID: 5161980 [No Abstract] [Full Text] [Related]
39. [Comments on the use of MPA 150 in a Family Planning Center]. Molitor MP Bull Soc Sci Med Grand Duche Luxemb; 1974 Apr; 111(1):49-53. PubMed ID: 4857538 [No Abstract] [Full Text] [Related]
40. Oral contraceptives and thrombosis. Aznar J; Mira Y; Vayá A Clin Appl Thromb Hemost; 2004 Apr; 10(2):189-90. PubMed ID: 15094942 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]